Selank Peptide

Selank comes out of a specific research tradition

Selank is a synthetic analogue of tuftsin, an immunomodulatory peptide fragment, developed at the Institute of Molecular Genetics in Russia and reportedly approved there for anxiety disorders. This section holds 5 lines from £32 to £78, averaging near £56.

It belongs to the same lineage as semax and, in evidential terms, sits alongside epitalon: real published research, concentrated in one national research tradition, with limited independent replication in Western literature.

What the research reports

Studies describe anxiolytic effects without sedation, and without the dependence and withdrawal associated with benzodiazepines. Proposed mechanisms include effects on GABAergic and serotonergic signalling and on BDNF expression.

Anxiolysis without sedation or dependence would be a genuinely valuable combination, which is exactly why the evidential caveat matters. The claim is attractive enough to deserve a higher standard of proof than it currently has outside its country of origin.

Why replication matters here specifically

Anxiety outcomes are subjective and placebo-responsive, more so than almost any endpoint in this catalogue. A compound with genuinely modest effects can produce convincing user reports, and only controlled independent work separates the two.

That does not mean it does nothing. It means the confident claims made about it rest on a narrower base than the volume of them suggests.

Practical points

Selank is commonly used intranasally as well as by injection, which is unusual in the peptides range and reflects its small size. It is not suppressive, not androgenic, and requires no PCT.

It is not a licensed medicine in the UK. Anyone with a diagnosed anxiety disorder is dealing with a clinical matter and a research peptide bought online is not a substitute for treatment.

What we will not tell you

We will not describe it as a proven anxiolytic, a benzodiazepine replacement, or a treatment for anything. The research is genuine and it does not support those statements at the confidence with which they are usually made.

The same reasoning applied to epitalon applies here, and for the same structural reason: a body of work concentrated in one place is in a different evidential position from one reproduced independently.

How it is usually taken

Intranasal administration is common because the molecule is small enough to be absorbed that way, which avoids injection entirely. That convenience is part of its appeal and it also means dosing is less precise than an injected volume would be.

Frequently asked questions

Is selank approved anywhere?
Reportedly in Russia for anxiety disorders. It is not licensed in the UK.

Is it like a benzodiazepine?
Research reports anxiolytic effects without the sedation or dependence associated with benzodiazepines.

How strong is the evidence?
Real but concentrated in one research tradition, with limited independent replication.

Can it be taken intranasally?
Yes, which is unusual for a peptide and reflects its small size.

Does it need PCT?
No. It does not act on the androgen axis.